Interaction of stable prostaglandin endoperoxide analogs U46619 and U44069 with human platelet membranes: Coupling of receptors with high-affinity GTPase and adenylate cyclase
- 1 October 1985
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 40 (1) , 101-112
- https://doi.org/10.1016/0049-3848(85)90354-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Ni‐mediated inhibition of human platelet adenylate cyclase by thrombinEuropean Journal of Biochemistry, 1984
- What turns platelets on?Trends in Biochemical Sciences, 1984
- Vasopressin inhibits the adenylate cyclase activity of human platelet particulate fraction through V1‐receptorsFEBS Letters, 1983
- Elevation of cytoplasmic free calcium concentration by stable thromboxane A2 analogue in human plateletsBiochemical and Biophysical Research Communications, 1983
- Synergistic inhibition of human platelet adenylate cyclase by stable GTP analogs and epinephrineBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983
- Epinephrine inhibits adenylate cyclase and stimulates a GTPase in human platelet membranes vis α‐adrenoceptorsFEBS Letters, 1981
- ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclaseNature, 1979
- A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2Biochemical and Biophysical Research Communications, 1977
- Interralation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3′,5′-adenosine monophosphate in human blood plateletsBiochimica et Biophysica Acta (BBA) - General Subjects, 1977
- Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane A2Prostaglandins, 1977